HK Stock Market Move | Bayzed Health (02609) soared another 50% to a new high, with its stock price increasing by 1.4 times in just two trading days. Its total market value has exceeded 20 billion Hong Kong dollars.

BAYZED HEALTH (02609) soared by more than 50%, reaching a high of HK$17.06, setting a new record high. In the past two trading days, the stock price has increased by 1.3 times. As of the announcement, the stock has risen by 58.01% to HK$16.19, with a trading volume of HK$1.437 billion and a total market value exceeding HK$20 billion. On the news front, the Shanghai and Shenzhen Stock Exchanges recently announced that BAYZED HEALTH has been included in the list of Hong Kong stock connect securities, effective from September 8th. The latest data shows that BAYZED HEALTH's holdings through the Hong Kong stock connect account for 0.21%. Public information shows that BAYZED HEALTH is a service provider in the field of "comprehensive cancer care services," providing screening, diagnosis, treatment, rehabilitation, and other services in the comprehensive cancer care service system. In terms of strategic layout, BAYZED HEALTH has successfully operated eight hospitals in Beijing, Tianjin, Anhui, Shanxi, and Henan provinces and cities. In the first half of this year, BAYZED HEALTH achieved a revenue of RMB 575 million, a year-on-year increase of 0.66%; shareholders' net loss was RMB 27.62 million, a year-on-year increase of 139.18%.